Sr. Product Designer · via Route 66 Ventures · 2025–Present
Lead product design for Sitebuilder, an internal platform enabling rapid deployment of healthcare clinic websites. Designed marketing collateral automation system using Claude AI, reducing production time by 80%.
Sr. Product Designer · Clinical Studies Platform · 2025
Engineered a marketing automation tool using AI to generate landing pages and ad copy from clinical study documents, cutting campaign launch time from 6 hours to 30 minutes. Prototyped 'Heartbeats,' a token-based gamification engine for clinical study engagement.
Sr. Product Designer · $8.25M raised · 2025
Redesigned the user onboarding experience and primary dashboard to streamline user workflows for this preventative health platform.
Sr. Product Designer · $1.5M raised · 2024
Led product design for a core feature enabling users to apply AI-driven nutrition insights toward personal goals, including managing a successful design sprint.
Sr. Product Designer · Series D · $1.25B valuation · 2022–2023
Oversaw the strategic transition of the native Android application, used by millions of users, to a unified React Native platform. Collaborated with engineering to execute experiments and ensure seamless UX.
Sr. Product Designer · Y Combinator W21 · 2022
Led the ground-up design of a novel maternal telehealth platform, translating MVP insights into a comprehensive web app. Innovated on the business model by designing a credit-based payment system for booking appointments.
Sr. Product Designer · Subsidiary of Yara International · 2021–2022
Conducted in-depth research and prototyped a platform to incentivize farmers to adopt sustainable, carbon-neutral practices by earning and selling carbon credits.
Sr. Product Designer · Fortune 500 · NASDAQ: AMAT · 2020–2021
Collaborated with the leading semiconductor manufacturer to develop an automated pricing platform and a comprehensive ERP solution for pharmaceutical companies.
Sr. Product Designer · Subsidiary of Konica Minolta · 2020
Designed a platform focused on COVID-19 assessment and testing to facilitate a safer return to work.